Enulose and Lexapro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enulose (lactulose) and Lexapro (escitalopram oxalate). Common drug interactions include oropharyngeal pain among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Enulose and Lexapro. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Enulose?

Enulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 711 Enulose users. Check the latest studies of Enulose.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.



On Jul, 12, 2026

43 people who take Enulose and Lexapro together, and have interactions are studied.

Enulose and Lexapro drug interactions.

What are the common drug interactions of Enulose and Lexapro, by gender? *:

female:

  1. Oropharyngeal pain
  2. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  3. Anaemia (lack of blood)
  4. Confusional state
  5. Drug ineffective
  6. Hepatic enzyme increased
  7. Abdominal pain
  8. Antinuclear antibody positive
  9. Biliary obstruction
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

  1. Diarrhoea
  2. Dyspnoea (difficult or laboured respiration)
  3. Hallucination, visual (seeing things that aren't there)
  4. Loss of consciousness
  5. Lymphadenitis (inflammation or enlargement of a lymph node)
  6. Nervousness
  7. Pain
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Road traffic accident
  10. Anger

What are the common drug interactions of Enulose and Lexapro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Death

40-49:

  1. Abnormal behaviour
  2. Agitation (state of anxiety or nervous excitement)
  3. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  4. Dental caries
  5. Drug dependence
  6. Dysphonia (speech disorder attributable to a disorder of phonation)
  7. Dyspnoea (difficult or laboured respiration)
  8. Dysuria (painful or difficult urination)
  9. Emotional distress
  10. Fall

50-59:

  1. Cataract (clouding of the lens inside the eye)
  2. Cellulitis (infection under the skin)
  3. Chest discomfort
  4. Chronic kidney disease
  5. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  6. Colostomy
  7. Connective tissue disorder (any disease that has the connective tissues of the body)
  8. Death
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

60+:

  1. Leukocytosis (increased white blood cells)
  2. Nausea (feeling of having an urge to vomit)
  3. Night sweats (sweating in night)
  4. Oropharyngeal pain
  5. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Dyspnoea (difficult or laboured respiration)
  8. Abdominal pain
  9. Anaemia (lack of blood)
  10. Biliary obstruction

What are the existing conditions these people have? *

  1. Pain: 24 people, 55.81%
  2. Stress And Anxiety: 9 people, 20.93%
  3. Dyspnea (difficult or laboured breathing): 6 people, 13.95%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 13.95%
  5. Lung Cancer - Non-Small Cell (lung cancer): 6 people, 13.95%
  6. Splenic Vein Thrombosis (blood clot in splenic vein): 4 people, 9.30%
  7. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 4 people, 9.30%
  8. Nausea (feeling of having an urge to vomit): 4 people, 9.30%
  9. Muscle Spasms (muscle contraction): 4 people, 9.30%
  10. Inflammation: 4 people, 9.30%

* Approximation only. Some reports may have incomplete information.

Do you take Enulose and Lexapro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Enulose and Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enulose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lactulose and escitalopram oxalate (the active ingredients of Enulose and Lexapro, respectively), and Enulose and Lexapro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: